Written question asked by Chris Green (Conservative) on Wednesday, 22 November 2023, in the House of Commons. It was due for an answer on Monday, 27 November 2023. It was answered by Andrew Stephenson (Conservative) on Tuesday, 28 November 2023 on behalf of the Department of Health and Social Care.
Rare Diseases: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, with reference to the Answer of 20 October 2023 to Question 202779 on Rare Diseases: Drugs, how many single technology appraisals of medicines conducted by the National Institute for Health and Care Excellence for non-orphan medicines resulted in (a) a positive recommendation, (b) an optimised recommendation, (c) a recommendation for managed access, (d) a negative recommendation and (e) termination in each financial year since 2018-19.
- Answer
-
The information requested is provided in the attached table.
Secondary information
- Type
- Written question
- Reference
- 3244
- Session
- 2023-24
- Attachment
- Rare Diseases
- Related items
- Subjects
- Drugs National Institute for Health and Care Excellence Rare diseases
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-28 13:57:45 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/3244
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/3244
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/3244